Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin
Pérez-Peña J, Díaz-Rodríguez E, Sanz E, Pandiella A. Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin. Nutrients. 2019 May 14;11(5). pii: E1068. doi: 10.3390/nu11051068. PubMed PMID: 31091680; PubMed Central PMCID: PMC6566638.
Multicomponent nutritional supplement Oncoxin and its influence on quality of life and therapy toxicity in patients receiving adjuvant chemotherapy
Kaidarova DR, Kopp MV, Pokrovsky VS, Dzhugashvili M, Akimzhanova ZM, Abdrakhmanov RZ, Babich EN, Bilan EV, Byakhov AV, Gurov SN, Koroleva IA, Mochalova AS, Povaga SS, Raigorodsky MV, Saifullin AS, Sanz E, Petrovskiy FI. Multicomponent nutritional supplement Oncoxin and its influence on quality of life and therapy toxicity in patients receiving adjuvant chemotherapy. Oncol Lett. 2019 Nov;18(5):5644-5652. doi: 10.3892/ol.2019.10868. Epub 2019 Sep 13. PubMed PMID: 31641390; PubMed Central PMCID: PMC6798186.
Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance
Hernandez-Unzueta I, Benedicto A, Romayor I, Herrero A, Sanz E, Arteta B, Olaso E, Márquez J. Ocoxin Oral Solution Exerts an Antitumoral Effect in
Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance. Pancreas. 2019 Apr;48(4):555-567. doi: 10.1097/MPA.0000000000001277. PubMed PMID: 30946238; PubMed Central PMCID: PMC6493672.
Oncoxin nutritional supplement in the management of chemotherapy- and/or radiotherapy-associated oral mucositis
Shumsky A, Bilan E, Sanz E, Petrovskiy F. Oncoxin nutritional supplement in the management of chemotherapy- and/or radiotherapy-associated oral mucositis. Mol Clin Oncol. 2019 Apr;10(4):463-468. doi: 10.3892/mco.2019.1809. Epub 2019 Feb 14. PubMed PMID: 30931119; PubMed Central PMCID: PMC6425507.
Efficacy and Safety of Oncoxin-Viusid, a Nutritional Supplement, in Twenty Patients with Stage IIB-III of Cutaneous Melanoma: An open-Label Proof of Concept Study
Gray Lovio OR, Daniel AA, García Yánez LA, Rodríguez MO, González CV, et al. (2019) Efficacy and Safety of Oncoxin-Viusid, a Nutritional Supplement, in Twenty Patients with Stage IIB-III of Cutaneous Melanoma: An open-Label Proof of Concept Study. J Cancer Sci Ther 11: 260-265.
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma
Hernández-SanMiguel E, Gargini R, Cejalvo T, Segura-Collar B, Núñez-Hervada P, Hortigüela R et al. Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma. Oxidative Medicine and Cellular Longevity. 2019;2019:1-12. DOI: 10.1155/2019/9719730
Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer
Díaz-Rodríguez E, Sanz E, Pandiella A. Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer. Int J Oncol. 2018 Jul;53(1):113-123. doi: 10.3892/ijo.2018.4373. Epub 2018 Apr 16. PubMed PMID: 29658597; PubMed Central PMCID: PMC5958831.
Findings of the 3-Month Supportive Treatment with Oncoxin Solution Beside the Standard Modalities of Patients with Different Neoplastic Diseases
Uddin, Dayem & Islam, MA & Mahmood, I & Ghosh, AK & Khatun, RA & Kundu, S. (2018). Findings of the 3-Month Supportive Treatment with Oncoxin Solution Beside the Standard Modalities of Patients with Different Neoplastic Diseases.. TAJ: Journal of Teachers Association. 22. 172. 10.3329/taj.v22i2.37718.
Oncoxin-Viusid with Radiotherapy and Chemotherapy in Patients with Head and Neck Cancer: Results from a Phase II, Randomised, Double-Blind Study
Rivas IC, Silva JA, Alfonso G, Candanedo H, Cuervo Y, et al. (2018) Oncoxin-Viusid with Radiotherapy and Chemotherapy in Patients with Head and Neck Cancer: Results from a Phase II, Randomised, Double-Blind Study. J Cancer Sci Ther 10: 317-327. DOI: 10.4172/1948-5956.1000562
Ocoxin oral solution® as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver
Hernandez-Unzueta I, Benedicto A, Olaso E, Sanz E, Viera C, Arteta B, Márquez J. Ocoxin oral solution(®) as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver. Oncol Lett. 2017 Jun;13(6):4002-4012. doi: 10.3892/ol.2017.6016. Epub 2017 Apr 10. PubMed PMID: 28599406; PubMed Central PMCID: PMC5453048.
Antitumoral effect of Ocoxin in hepatocellular carcinoma
Díaz-Rodríguez E, El-Mallah AM, Sanz E, Pandiella A. Antitumoral effect of Ocoxin in hepatocellular carcinoma. Oncol Lett. 2017;14(2):1950–1958. doi:10.3892/ol.2017.6440
Antitumoral effect of Ocoxin on acute myeloid leukemia
Díaz-Rodríguez E, Hernández-García S, Sanz E, Pandiella A. Antitumoral effect of Ocoxin on acute myeloid leukemia. Oncotarget. 2016;7(5):6231–6242. doi:10.18632/oncotarget.6862
Novel approaches for the correction of micronutrient deficiency in patients with malignant tumors
DZHUGASHVILI M. POKROVSKY V. S. SNEGOVOY A. V. Novel approaches for the correction of micronutrient deficiency in patients with malignant tumors. Malignant Tumours 2016; 2: 55-65. DOI: 10.18027/2224-5057-2016-2-55-65
Effect of Oncoxin Oral Solution in HER2-Overexpressing Breast Cancer
Hernández-García S, González V, Sanz E, Pandiella A. Effect of Oncoxin Oral Solution in HER2-Overexpressing Breast Cancer. Nutr Cancer. 2015;67(7):1159-69. doi: 10.1080/01635581.2015.1068819. Epub 2015 Aug 4. PubMed PMID: 26241555.
Ocoxin® oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice
Márquez J, Mena J, Hernandez-Unzueta I, Benedicto A, Sanz E, Arteta B, Olaso E. Ocoxin® oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice. Oncol Rep. 2016 Mar;35(3):1265-72. doi: 10.3892/or.2015.4486. Epub 2015 Dec 16. PubMed PMID: 26676882; PubMed Central PMCID: PMC4750781.
Increased survival of patients with end-stage hepatocellular carcinoma due to intake of ONCOXIN®, a dietary supplement.
Al-Mahtab M, Akbar SM, Khan MS, Rahman S. Increased survival of patients with end-stage hepatocellular carcinoma due to intake of ONCOXIN®, a dietary supplement. Indian J Cancer. 2015 Jul-Sep;52(3):443-6. doi: 10.4103/0019-509X.176699. PubMed PMID: 26905163.